Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Biomedica ; 32(1): 13-22, 2012.
Artigo em Espanhol | MEDLINE | ID: mdl-23235783

RESUMO

INTRODUCTION: Damage of testicles is frequent in lepromatous leprosy and worsened by the presence of erythema nodosum leprosum. Objective. A patient is presented who developed lepromatous leprosy and erythema nodosum leprosum with major testicular compromise. MATERIAL AND METHODS: The 28-year-old male patient had lepromatous leprosy since age 22. During a polychemotherapy treatment for the lepromatous leprosy, he presented chronic erythema nodosum leprosum that affected both testicles; he did not respond to the conventional treatment. A left orchidectomy was performed to treat the persistent pain. RESULTS: The extracted testis evidenced the following: tubular atrophy, extensive fibrosis, cumulus of foamy macrophages without rods, focal Leydig cell hyperplasia, linfocitary and granulomatous arteritis and endarteritis of small and medium size vessels. These changes were also observed in the epididymis. Two years after the polychemoterapy and the orchidectomy, the patient exhibited azoospermy, normal total testosterone, slightly diminished free testosterone and elevated levels of luteinizing hormone and follicle-stimulating hormone. No loss of libido or sexual activity was reported. General concepts of erythema nodosum leprosum were reviewed, as well as the pathologic changes produced by leprosy in the testis. CONCLUSION: Lepromatous leprosy may lead to hypogonadism. This condition is recommended for inclusion in leprosy diagnostic programs in order to detect and treat the consequences of the possible hypogonadism.


Assuntos
Eritema Nodoso/etiologia , Hipogonadismo/etiologia , Hanseníase Virchowiana/complicações , Doenças Testiculares/etiologia , Adulto , Atrofia , Azoospermia/etiologia , Clofazimina/uso terapêutico , Dapsona/uso terapêutico , Epididimo/patologia , Eritema Nodoso/patologia , Eritema Nodoso/cirurgia , Fibrose , Células Espumosas/patologia , Hormônio Foliculoestimulante/sangue , Humanos , Hiperplasia , Hipogonadismo/sangue , Hansenostáticos/uso terapêutico , Hanseníase Virchowiana/classificação , Hanseníase Virchowiana/tratamento farmacológico , Hanseníase Virchowiana/imunologia , Hanseníase Virchowiana/patologia , Células Intersticiais do Testículo/patologia , Hormônio Luteinizante/sangue , Masculino , Orquiectomia , Rifampina/uso terapêutico , Doenças Testiculares/patologia , Doenças Testiculares/cirurgia , Testosterona/sangue , Talidomida/uso terapêutico
2.
Biomédica (Bogotá) ; 32(1): 13-22, ene.-mar. 2012. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-639807

RESUMO

Introducción. La afección testicular es frecuente en la lepra lepromatosa, daño que se incrementa cuando cursa con eritema nudoso leproso. Objetivo. Presentar un paciente con lepra lepromatosa y eritema nudoso leproso con grave compromiso testicular. Materiales y métodos. Se estudió un hombre de 28 años con lepra lepromatosa desde los 22, que durante la poliquimioterapia para la lepra presentó eritema nudoso leproso crónico que afectó ambos testículos y no respondió al manejo convencional. El dolor persistente obligó a practicar orquidectomía izquierda. Resultados. Este testículo presentaba atrofia tubular y fibrosis notorias, conglomerados de macrófagos espumosos, sin bacilos, hiperplasia focal de células de Leydig, endarteritis y arteritis linfocitaria y granulomatosa de vasos pequeños y medianos; estos cambios también estaban presentes en el epidídimo. Un estudio llevado a cabo dos años después de terminar su tratamiento y de la orquidectomía izquierda, demostró azoospermia, testosterona total normal, testosterona libre discretamente disminuida y hormonas lutropina (luteinizante) y folitropina (estimulante del folículo) elevadas. No había disminución de la libido ni de su actividad sexual. Se revisaron los conceptos generales sobre el eritema nudoso leproso y las alteraciones que la lepra produce en el testículo. Conclusión. La lepra lepromatosa puede conducir a hipogonadismo. Los programas de lepra deben contemplar esta complicación para corregir y evitar sus secuelas.


Introduction. Damage of testicles is frequent in lepromatous leprosy and worsened by the presence of erythema nodosum leprosum. Objective. A patient is presented who developed lepromatous leprosy and erythema nodosum leprosum with major testicular compromise. Material and methods. The 28-year-old male patient had lepromatous leprosy since age 22. During a polychemotherapy treatment for the lepromatous leprosy, he presented chronic erythema nodosum leprosum that affected both testicles; he did not respond to the conventional treatment. A left orchidectomy was performed to treat the persistent pain. Results. The extracted testis evidenced the following: tubular atrophy, extensive fibrosis, cumulus of foamy macrophages without rods, focal Leydig cell hyperplasia, linfocitary and granulomatous arteritis and endarteritis of small and medium size vessels. These changes were also observed in the epididymis. Two years after the polychemoterapy and the orchidectomy, the patient exhibited azoospermy, normal total testosterone, slightly diminished free testosterone and elevated levels of luteinizing hormone and follicle-stimulating hormone. No loss of libido or sexual activity was reported. General concepts of erythema nodosum leprosum were reviewed, as well as the pathologic changes produced by leprosy in the testis. Conclusion. Lepromatous leprosy may lead to hypogonadism. This condition is recommended for inclusion in leprosy diagnostic programs in order to detect and treat the consequences of the possible hypogonadism.


Assuntos
Adulto , Humanos , Masculino , Eritema Nodoso/etiologia , Hipogonadismo/etiologia , Hanseníase Virchowiana/complicações , Doenças Testiculares/etiologia , Atrofia , Azoospermia/etiologia , Clofazimina/uso terapêutico , Dapsona/uso terapêutico , Epididimo/patologia , Eritema Nodoso/patologia , Eritema Nodoso/cirurgia , Fibrose , Células Espumosas/patologia , Hormônio Foliculoestimulante/sangue , Hiperplasia , Hipogonadismo/sangue , Hansenostáticos/uso terapêutico , Hanseníase Virchowiana/classificação , Hanseníase Virchowiana/tratamento farmacológico , Hanseníase Virchowiana/imunologia , Hanseníase Virchowiana/patologia , Células Intersticiais do Testículo/patologia , Hormônio Luteinizante/sangue , Orquiectomia , Rifampina/uso terapêutico , Doenças Testiculares/patologia , Doenças Testiculares/cirurgia , Testosterona/sangue , Talidomida/uso terapêutico
3.
Int J Lepr Other Mycobact Dis ; 68(3): 258-66, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11221087

RESUMO

This study was conducted to determine if osteoporosis in male leprosy patients is caused by testicular atrophy. Bone volume (BV/TV), trabecular number (TbN), trabecular thickness (TbTh), and trabecular separation (TbSp) were measured in two areas in decalcified paraffin sections of lumbar bones from 29 male leprosy and 6 male nonleprosy autopsy cases. We found significant differences in the average BV/TV measurements among the 7 patients with nodular Leydig cell hyperplasia (BV/TV 12.24%) and the 22 patients without hyperplasia (BV/TV 7.35%) and 6 patients without leprosy (BV/TV 12.98%). Bone volume was maintained in patients with nodular Leydig cell hyperplasia, and we determined no clinical factor other than the Leydig cell hyperplasia that reflected the bone volume. The osteoporosis of male leprosy patients was attributed to secondary gonadal dysfunction due to testicular atrophy, and Leydig cell hyperplasia appears to preserve bone volume.


Assuntos
Hanseníase/patologia , Vértebras Lombares/patologia , Osteoporose/patologia , Testículo/patologia , Idoso , Densidade Óssea , Histocitoquímica , Humanos , Hiperplasia/patologia , Processamento de Imagem Assistida por Computador , Hanseníase/complicações , Células Intersticiais do Testículo/patologia , Masculino , Pessoa de Meia-Idade , Osteoporose/complicações , Estatísticas não Paramétricas
4.
Lepr India ; 54(1): 48-55, 1982 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-7098442

RESUMO

Twenty five patients of lepromatous leprosy were studied clinically and histopathologically for testicular involvement. Testicular pain or swelling was the commonest complaint (68%) followed by sterility (28%) and impotence (4%). Reduced testicular size associated with soft feel was observed in 76% patients. Gynaecomastia was present in 36% and altered sexual hair pattern in 24%. Eleven out of sixteen (69%) patients had oligo/azoospermia. Out of the twenty testicular biopsies 15 (75%) had definite histological evidence of leprous pathology, irrespective of testicular size, semen picture and clinical signs and symptoms. One out of three epididymal biopsies showed minimal changes. Histopathological changes varied markedly, it was not possible to categorize these into vascular, interstitial and obliterative phases.


Assuntos
Hanseníase/patologia , Orquite/patologia , Testículo/patologia , Adolescente , Adulto , Idoso , Atrofia , Humanos , Hanseníase/complicações , Hanseníase/imunologia , Células Intersticiais do Testículo/patologia , Masculino , Pessoa de Meia-Idade , Orquite/etiologia , Orquite/imunologia , Túbulos Seminíferos/patologia
5.
s.l; s.n; jan. 1982. 8 p. ilus.
Não convencional em Inglês | Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1240443

RESUMO

Twenty five patients of lepromatous leprosy were studied clinically and histopathologically for testicular involvement. Testicular pain or swelling was the commonest complaint (68%) followed by sterility (28%) and impotence (4%). Reduced testicular size associated with soft feel was observed in 76% patients. Gynaecomastia was present in 36% and altered sexual hair pattern in 24%. Eleven out of sixteen (69%) patients had oligo/azoospermia. Out of the twenty testicular biopsies 15 (75%) had definite histological evidence of leprous pathology, irrespective of testicular size, semen picture and clinical signs and symptoms. One out of three epididymal biopsies showed minimal changes. Histopathological changes varied markedly, it was not possible to categorize these into vascular, interstitial and obliterative phases.


Assuntos
Masculino , Humanos , Adulto , Pessoa de Meia-Idade , Idoso , Adolescente , Atrofia , Células Intersticiais do Testículo/patologia , Hanseníase/complicações , Hanseníase/imunologia , Hanseníase/patologia , Orquite/etiologia , Orquite/imunologia , Orquite/patologia , Testículo/patologia , Túbulos Seminíferos/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA